Chelation Therapy An Alternative to Bypass Surgery
(A Patient’s Report by Dean Baxter, Director of Public Affairs • Arco
Corporation • Houston,
Coronary artery bypass surgery is a definitive and final approach to increase
oxygen supply to the heart. Most cardiologists agree that when all pharmaceutical
modalities fail to increase oxygenation and reduce workload of the heart,
a surgical bypass is indicated. Statistics reveal 75-90% of patients who
are appropriate operative candidates and survive surgery have reduction
or disappearance of angina symptoms. Whether or not bypass surgery prolongs
life is controversial.
Relative mortality risk for bypass surgery is 4% for “good” surgical
candidates. Nearly 20% of operated patients develop a heart attack during
the recovering period.
The above statistics are under dispute. Some observers state mortality
rates for bypass surgery are 7.2-11.8%. A study at Mt. Sinai Hospital in
City indicates mortality rates at 4.5% for centers performing 200 or more
surgeries yearly, 9% for those centers performing 100 to 200 cases, and
12% in centers performing less than 100 bypass surgeries. The risk of heart
following bypass surgery is between 5% and 40%. Reports demonstrate that
15-30% of vein grafts (used in the bypass) become obstructed in one year.
There are research reports showing little or no beneficial improvement
of heart muscle functioning after bypass surgery.
Financially, bypass coronary surgery is good business. In 1976, 80,000
patients underwent bypass surgery at an average cost of $32,000 for the
This totals $3 billion yearly. If this trend continues, there can be nearly
one-quarter million patients having the surgery in the upcoming years at
an expense of $100 billion. Thus surgery provides a busy cardiac surgeon
the opportunity to earn one to two million dollars each year.
With these medical and financial considerations in mind, we need alternative
approaches for severe coronary artery disease. One process, known as EDTA
chelation therapy, is an alternative to bypass surgery. The following report
by Dean Baxter, a retired oil executive of Arco, provides some insights
into this chelation process.
Jonathan Collin, M.D.
Reprinted from the Port
Townsend Health Letter—Summer 1991
Jonathan Collin, MD
FAMILY PRACTICE • NUTRITIONAL MEDICINE • CHELATION DIPLOMATE
• EDTA Chelation for Circulatory Problems & Toxic Metal Poisoning • Thyroid
Diagnosis • Homeopathy Prescription •PMS • Fatigue/Anxiety,
Depression Work-Up • Nutritional Analysis and Counseling • Stress
Evaluation & Health Risk Report •
• Vitamin Supplementation Program • Elimination Diet and Allergy
Testing • Weight Management • Physical Check-Up & Laboratory
Exam • Vitamin Injection •
Dr. Collin maintains two offices in
911 Tyler Street
Port Townsend, WA 98368
Monday: 10:30 a.m. to 5 p.m.
Tuesday: 8 a.m. to 5 p.m.
Wednesday: 8 a.m. to noon
12911 120th Avenue NE, Suite A-50
P.O. Box 8099
Kirkland, WA 98034
Wednesday: 3:30 to 7 p.m.
Thursday: 8:30 a.m. to 5 p.m.
Friday: 9 a.m. to 5 p.m.
Saturday: 8 a.m. to noon